<p>Invokana is a diabetes medicine that contains the active substance canagliflozin. It is used together with diet and exercise to treat adults and children above the age of 10 years with type 2 diabetes.</p><p>Invokana can be used on its own in patients who cannot take metformin (another diabetes medicine) or it can be used as an ‘add-on’ to other diabetes medicines.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Invokana is indicated for the treatment of adults and children aged 10 years and older with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise: </p><ul><li>as monotherapy when metformin is considered inappropriate due to intolerance or contraindications</li><li>in addition to other medicinal products for the treatment of diabetes.</li></ul><p>For study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4.4, 4.5 and 5.1.</p></div>
Therapeutic Area (MeSH)
ATC Code
A10BK02
ATC Item
N/A
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| canagliflozin | N/A | canagliflozin |
EMA Name
Invokana
Medicine Name
Invokana
Aliases
N/ANo risk management plan link.
